Correlation Between HUTCHMED DRC and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Citius Oncology,, you can compare the effects of market volatilities on HUTCHMED DRC and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Citius Oncology,.
Diversification Opportunities for HUTCHMED DRC and Citius Oncology,
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HUTCHMED and Citius is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Citius Oncology, go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Citius Oncology,
Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 0.34 times more return on investment than Citius Oncology,. However, HUTCHMED DRC is 2.94 times less risky than Citius Oncology,. It trades about 0.03 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.22 per unit of risk. If you would invest 1,371 in HUTCHMED DRC on August 26, 2024 and sell it today you would earn a total of 365.00 from holding HUTCHMED DRC or generate 26.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 15.09% |
| Values | Daily Returns |
HUTCHMED DRC vs. Citius Oncology,
Performance |
| Timeline |
| HUTCHMED DRC |
| Citius Oncology, |
HUTCHMED DRC and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HUTCHMED DRC and Citius Oncology,
The main advantage of trading using opposite HUTCHMED DRC and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| HUTCHMED DRC vs. Capricor Therapeutics | HUTCHMED DRC vs. Akari Therapeutics PLC | HUTCHMED DRC vs. Soleno Therapeutics | HUTCHMED DRC vs. Bio Path Holdings |
| Citius Oncology, vs. Getty Realty | Citius Oncology, vs. Mangazeya Mining | Citius Oncology, vs. Waste Management | Citius Oncology, vs. Alvotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |